BiOptic Profit Margin

BiOptic (6850.TWO) currently reports a profit margin of 6.57% as of June 2026. That compares with 18.08% in the prior-year period — down 63.6% year over year. That is below the Healthcare sector average of 9.48%. Use the charts on this page to explore BiOptic's profit margin history and peer comparisons.

BiOptic's profit margin decreased from 18.08% to 6.57% — a 63.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BiOptic's profit margin of 6.57% is lower than the Healthcare sector average of 9.48%. That is roughly 30.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but BiOptic's current 6.57% should be judged against Healthcare norms (sector average: 9.48%) and against 6850.TWO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 6.57%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 9.48%. From there, open related valuation or income-statement pages for BiOptic, and consider following 6850.TWO for alerts when major investors trade the stock.